SlideShare a Scribd company logo
1 of 4
Download to read offline
Standalone Results In Cr.
Particulars Qtr Ending Qtr Ending
Mar 15 Mar 14 Var. (%)
Sales 7675.63 7094.10 8
OPM (%) 17.20 15.20
OP 1318.18 1077.55 22
Other Income 98.41 150.63 -35
PBIDT 1416.59 1228.18 15
Interest (Income)/expenses 0.00 5.33 -100
PBDT 1416.59 1222.85 16
Depreciation 70.52 65.77 7
PBT before EO 1346.07 1157.08 16
Exceptional Items 179.40 66.03 172
PBT after EO 1525.47 1223.11 25
Total Tax 507.39 350.98 45
Net profit 1018.08 872.13 17
EPS 4.71 4.03
May 14, 2015Hindustan Unilever Limited
Current Price:
Price (`) 843.05
52 W H/L(`) 979.00/554.55
Mkt. Cap.(` Cr) 182390.91
Latest Equity(Subscribed) 216.35
Latest Reserve 3507.76
Latest EPS-Unit Curr. 17.80
Latest P/E Ratio 47.36
Latest Bookvalue -Unit Curr. 17.21
Latest P/BV 48.99
Dividend Yield -% 1.54
Face Value 1.00
VALUE PARAMETERS
`843.05
STOCK DATA
BSE Code 500696
NSE Symbol HINDUNILVR
Reuters HLL.BO
Bloomberg HUVR IN
Hindustan Unilever (HUL) matched street estimates with the fourth quarter profit
rising 16.7 percent year-on-year to `1,018 crore compared to `872 crore in the
year-ago period.
The net sales have increased by 8% to `7675.63 crore. The Domestic Consumer business grew
at 9%, with 6% underlying volume growth, both ahead of market.
In Soaps and Detergents, growth sustained. Skin Cleansing delivered volume-led growth driven
by Lifebuoy, Liril and Pears. The liquids portfolio registered another strong quarter led by
Lifebuoy Handwash. In Laundry, growth was led by the premium segment with Surf
maintaining its volume led double digit growth momentum and Rin delivering good growth on
the bars portfolio. Comfort Fabric Conditioners continued to do well. Vim led the performance in
Household Care. The quarter witnessed price deflation across these categories, as the benefit
of lower commodity costs was passed on to consumers.
Personal Products growth steps up across all categories. Skin Care delivered double digit
growth driven by Fair and Lovely and Pond's. Fair and Lovely continued to perform well while
Pond's growth was led by premium skin lightening and talc.
Hair Care sustained its strong volume led growth momentum with broad based double digit
growth. Dove led the category performance while Clinic Plus, Sunsilk and TRESemmé continued
to make very good progress.
In Oral Care, Close Up registered double digit growth on the back of impactful activation.
Pepsodent growth was driven by Gum Care and Clove & Salt variants.
Colour Cosmetics delivered innovation led double digit growth with Lakme continuing to
strengthen its position in premium make up, driven by a range of exciting and contemporary
offerings from Absolute and 9 to 5.
Beverages had strong growth in Tea and Coffee. Tea delivered double digit growth led by Taj
Mahal, Red Label and 3 Roses. Lipton Green Tea registered another quarter of high growth on
sustained market development. In Coffee, the performance was driven by Bru Gold, which
continued to lead category premiumization.
1
SHARE HOLDING PATTERN (%)
Description as on % of Holding
31/03/2015
Foreign 15.37
Institutions 3.82
Non Promoter Corp. Hold. 1.13
Promoters 67.23
Public & Others 12.45
®
2
Standalone Segmented Results
In Cr.
Particulars Qtr Ending Qtr Ending Var %
Mar 15 Mar 14 (%) of total
Soaps & Detergents 3673.71 3497.12 5 48
Personal Products 2249.68 1983.29 13 29
Beverages 976.15 869.04 12 13
Packaged Foods 476.83 419.68 14 6
Others 294.70 295.79 0 4
Total 7671.07 7064.92 9 100
Segment Results (PBIT)
Soaps & Detergents 488.25 421.71 16 37
Personal Products 624.52 495.81 26 48
Beverages 181.61 163.04 11 14
Packaged Foods 25.40 22.96 11 2
Others -7.83 -25.05 -69 -1
TOTAL 1311.95 1078.47 22 100
Packaged Foods had sixth successive quarter of double digit growth. Market development
continues to be the focus, resulting in double digit growth across all key brands. Kissan
sustained its strong activation-led growth momentum while Knorr registered volume led
growth as Instant Soups more than doubled sales and new Chinese flavours were added to the
Noodles portfolio. Ice Creams delivered another strong quarter, led by Magnum and sharper in-
market execution on Kwality Walls. A new variant, Magnum Choco Cappuccino was introduced
during the season.
Pureit growth was led by the premium segment with Ultima (RO+UV) continuing to deliver
strongly. The quarter saw the launch of a new Marvella (RO+UV) device.
Input costs were benign and this is reflected in the reduction in cost of goods sold. Investment
behind brands was sustained at competitive levels. The margin for the quarter includes a one-
time credit of Rs 71.5 crore towards a favourable outcome for a contested matter on Excise
Duty.
As a result, OPM inclined by 198 bps to 17.2%. There was fall in raw material cost by 220 bps to
38.08%, purchase of traded goods by 128 bps to 11.88%, employee cost by 20 bps to 5.05%
and other cost by 30 bps to 14.49% of adjusted net sales. However, there was rise
advertisement & promotion (ASP) cost by 170 bps to 13.36% of adjusted net sales. The
operating profit inclined by 22% to `1318.18 crore.
Other income has decreased by 35% to `98.41 crore, which includes interest income, dividend
income and net gain on sale of other non-trade current investments. Depreciation inclined by
7% to `70.52 crore. Profit before tax and exceptional item inclined by 16% to Rs 1346.07 crore.
There was an exceptional income of `179.40 crore, growth of 172%. Exceptional items includes
profit on sale of surplus properties `70.7 crore, profit on sale of wholly owned subsidiary Brooke
Bond Real Estate Pvt Ltd `168.97 crore, reduction in provision for retirement benefit arising out
of change in actuarial assumption of `5.37 crore and restructuring cost of `2.02 crore. The
profit before tax and after exceptional items has inclined by 25% to `1525.47 crore.
Tax outgo has increased by 45% to `507.39 crore. The effective tax rate was increased from
28.69% to 33.26%. The net profit has increased by 17% to Rs 1018.08 crore due to increase in
OPM and EO income.
®
3
®
Segmented results
Soaps & detergents: At standalone level, the revenue has increased by 5% to `3673.71 crore
for Q4 FY15. PBIT margins had inclined by 120 bps to 13.3%. As a result, PBIT had increased by
16% to `488.25 crore. The category contributed around 48% to the revenues while the
contribution to PBIT stood at 37%.
Personal care: At standalone level, the revenues grew 13% to `2249.68 crore for Q4 FY15.
PBIT margin have increased by 280 bps to 27.8%. As a result, the PBIT has increased by 26% to
`624.52 crore. The category contributed around 29% to the revenues while the contribution to
PBIT stood 48%.
Beverages: At standalone level, the sales grew by 12% to `976.15 crore for Q4 FY15. The
segment contributed 13% to the total revenues. PBIT margin has declined by 20 bps to 18.6%.
As a result, PBIT has inclined by 11% to `181.61 crore. It contributes 14% to the total PBIT.
Packaged Foods: At standalone level, the sales have increased by 14% to `476.83 crore for
Q4 FY15. The segment contributed 6% to the total revenues. PBIT margin declined by 14 bps to
5.3%.The PBIT has increased by11% to Rs 25.40 crore.
Other Business
At standalone level, the sales stood at `294.70 crore for Q4 FY15. The segment contributed 4%
to the total revenues. The loss at PBIT level decreased by 69% to `7.83 crore.
Other Developments
The Board of Directors has proposed a final dividend of `9 per share, subject to the approval of
the shareholders at the AGM. Together with the interim dividend of `6 per share, the total
dividend for the financial year ending 31st March, 2015 amounts to `15 per share.
Management Comments
Harish Manwani, Chairman commented: We have delivered another year of strong
performance with broad based growth ahead of the market and sustained margin
improvement. Our strategy remains focused on strengthening the core of our business through
innovation, leading market development and continuous improvement of our executional
capabilities. Despite market challenges, our strategic agenda remains unchanged as we
continue to manage our business even more dynamically for growth that is consistent,
competitive, profitable and responsible.
4
®
SMC Global Securities Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, a further public offering of its equity shares and has filed the Draft Red Herring
Prospectus with the Securities and Exchange Board of India (“SEBI”) and the Stock Exchanges. The Draft Red Herring Prospectus is available on the website of SEBI at www.sebi.gov.in and on the websites of the
Book Running Lead Manager i.e., ICICI Securities Limited at www.icicisecurities.com and the Co- Book Running Lead Manager i.e., Elara Capital (India) Private Limited at www.elaracapital.com . Investors should
note that investment in equity shares involves a high degree of risk and for details relating to the same, please see the section titled “Risk Factors” of the aforementioned offer document.
Disclaimer: This report is for the personal information of the authorized recipient and doesn't construe to be any investment, legal or taxation advice to you. It is only for private circulation and use .The report is based
upon information that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied upon as such. No action is solicited on the basis of the contents of the report. The report
should not be reproduced or redistributed to any other person(s)in any form without prior written permission of the SMC. The contents of this material are general and are neither comprehensive nor inclusive. Neither
SMC nor any of its affiliates, associates, representatives, directors or employees shall be responsible for any loss or damage that may arise to any person due to any action taken on the basis of this report. It does not
constitute personal recommendations or take into account the particular investment objectives, financial situations or needs of an individual client or a corporate/s or any entity/s.All investments involve risk and past
performance doesn't guarantee future results. The value of, and income from investments may vary because of the changes in the macro and micro factors given at a certain period of time. The person should use
his/her own judgment while taking investment decisions. Please note that we and our affiliates, officers, directors, and employees, including persons involved in the preparation or issuance if this material;(a) from
time to time, may have long or short positions in, and buy or sell the securities thereof, of company (ies) mentioned here in or (b) be engaged in any other transaction involving such securities and earn brokerage or
other compensation or act as a market maker in the financial instruments of the company (ies) discussed herein or may perform or seek to perform investment banking services for such company(ies) or act as advisor
or lender/borrower to such company(ies) or (c) may have any other potential conflict of interest with respect to any recommendation and related information and opinions.All disputes shall be subject to the exclusive
jurisdiction of Delhi High court.
Corporate Office:
11/6B, Shanti Chamber,
Pusa Road, New Delhi - 110005
Tel: +91-11-30111000
www.smcindiaonline.com
Mumbai Office:
Dheeraj Sagar, 1st Floor,
Opp. Goregaon sports club, link road
Malad (West), Mumbai - 400064
Tel: 91-22-67341600, Fax: 91-22-28805606
Kolkata Office:
18, Rabindra Sarani,
"Poddar Court", Gate No. 4,
4th Floor, Kolkata - 700001
Tel: 91-33-39847000, Fax: 91-33-39847004
E-mail: researchfeedback@smcindiaonline.com
®
SMC Research also available on Reuters
SMC Global Securities Ltd. (hereinafter referred to as “SMC”) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited and its associate is member of MCX stock
Exchange Limited. It is also registered as a Depository Participant with CDSL and NSDL. Its associates merchant banker and Portfolio Manager are registered with SEBI and NBFC registered with RBI. It also has
registration withAMFI as a Mutual Fund Distributor.
SMC is in the process of making an application with SEBI for registering as a Research Entity in terms of SEBI (Research Analyst) Regulations, 2014. SMC or its associates has not been debarred/ suspended by
SEBI or any other regulatory authority for accessing /dealing in securities Market.
SMC or its associates including its relatives/analyst do not hold any financial interest/beneficial ownership of more than 1% in the company covered byAnalyst. SMC or its associates and relatives does not have any
material conflict of interest. SMC or its associates/analyst has not received any compensation from the company covered byAnalyst during the past twelve months. The subject company has not been a client of SMC
during the past twelve months. SMC or its associates has not received any compensation or other benefits from the company covered by analyst or third party in connection with the research report. TheAnalyst has
not served as an officer, director or employee of company covered byAnalyst and SMC has not been engaged in market making activity of the company covered byAnalyst.
The views expressed are based solely on information available publicly available/internal data/ other reliable sources believed to be true.
SMC does not represent/ provide any warranty express or implied to the accuracy, contents or views expressed herein and investors are advised to independently evaluate the market conditions/risks involved before
making any investment decision.
SMC Research Desk

More Related Content

What's hot

Hindustan Media Q1FY15: Strong advertising as well as circulation growth, Buy
Hindustan Media Q1FY15: Strong advertising as well as circulation growth, BuyHindustan Media Q1FY15: Strong advertising as well as circulation growth, Buy
Hindustan Media Q1FY15: Strong advertising as well as circulation growth, BuyIndiaNotes.com
 
Alkyl Amine: The Making of a Multibagger
Alkyl Amine: The Making of a Multibagger Alkyl Amine: The Making of a Multibagger
Alkyl Amine: The Making of a Multibagger Amitabh Vatsya
 
Mahindra &Mahindra Q1FY15 profits better than estimates - Hold - SPA Securities
Mahindra &Mahindra Q1FY15 profits better than estimates - Hold - SPA SecuritiesMahindra &Mahindra Q1FY15 profits better than estimates - Hold - SPA Securities
Mahindra &Mahindra Q1FY15 profits better than estimates - Hold - SPA SecuritiesIndiaNotes.com
 
Godrej Consumer's Q4 results were slightly below expectations; Neutral
Godrej Consumer's Q4 results were slightly below expectations; NeutralGodrej Consumer's Q4 results were slightly below expectations; Neutral
Godrej Consumer's Q4 results were slightly below expectations; NeutralIndiaNotes.com
 
Dabur ru2 qfy2011-271010
Dabur ru2 qfy2011-271010Dabur ru2 qfy2011-271010
Dabur ru2 qfy2011-271010Angel Broking
 
Procter & Gamble Analysis
Procter & Gamble AnalysisProcter & Gamble Analysis
Procter & Gamble AnalysisDavid Hatfield
 
Sanofi India: Q2CY14 net rises 12.30%, maintain buy
 Sanofi India: Q2CY14 net rises 12.30%, maintain buy Sanofi India: Q2CY14 net rises 12.30%, maintain buy
Sanofi India: Q2CY14 net rises 12.30%, maintain buyIndiaNotes.com
 
Finacial comparison Godrej & Dabur
Finacial comparison Godrej & DaburFinacial comparison Godrej & Dabur
Finacial comparison Godrej & Daburnhluthra
 
Aviva plc Third Quarter 2014 Interim Management Statement
Aviva plc Third Quarter 2014 Interim Management StatementAviva plc Third Quarter 2014 Interim Management Statement
Aviva plc Third Quarter 2014 Interim Management StatementAviva plc
 
Arabian Food Industries - Domty - Initiation of Coverage - October 2016
Arabian Food Industries - Domty - Initiation of Coverage - October 2016Arabian Food Industries - Domty - Initiation of Coverage - October 2016
Arabian Food Industries - Domty - Initiation of Coverage - October 2016Omneya El Hammamy
 
Colgate Palmolive: Long-term outlook remains encouraging; Accumulate
Colgate Palmolive: Long-term outlook remains encouraging; AccumulateColgate Palmolive: Long-term outlook remains encouraging; Accumulate
Colgate Palmolive: Long-term outlook remains encouraging; AccumulateIndiaNotes.com
 
Narayan hrudyalaya Q1FY19
Narayan hrudyalaya Q1FY19Narayan hrudyalaya Q1FY19
Narayan hrudyalaya Q1FY19Karan Agarwal
 
DB Corp Q4FY15: Buy for a medium to long term investment
DB Corp Q4FY15: Buy for a medium to long term investmentDB Corp Q4FY15: Buy for a medium to long term investment
DB Corp Q4FY15: Buy for a medium to long term investmentIndiaNotes.com
 
Sharda Cropchem IPO: Reasonably priced; Subscribe - SPA Securities
Sharda Cropchem IPO: Reasonably priced; Subscribe - SPA SecuritiesSharda Cropchem IPO: Reasonably priced; Subscribe - SPA Securities
Sharda Cropchem IPO: Reasonably priced; Subscribe - SPA SecuritiesIndiaNotes.com
 
Aviva HY 2014 analyst presentation
Aviva HY 2014 analyst presentationAviva HY 2014 analyst presentation
Aviva HY 2014 analyst presentationAviva plc
 
Aviva 2017 Interim Results announcement
Aviva 2017 Interim Results announcementAviva 2017 Interim Results announcement
Aviva 2017 Interim Results announcementAviva plc
 
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'IndiaNotes.com
 

What's hot (20)

Hindustan Media Q1FY15: Strong advertising as well as circulation growth, Buy
Hindustan Media Q1FY15: Strong advertising as well as circulation growth, BuyHindustan Media Q1FY15: Strong advertising as well as circulation growth, Buy
Hindustan Media Q1FY15: Strong advertising as well as circulation growth, Buy
 
Alkyl Amine: The Making of a Multibagger
Alkyl Amine: The Making of a Multibagger Alkyl Amine: The Making of a Multibagger
Alkyl Amine: The Making of a Multibagger
 
Mahindra &Mahindra Q1FY15 profits better than estimates - Hold - SPA Securities
Mahindra &Mahindra Q1FY15 profits better than estimates - Hold - SPA SecuritiesMahindra &Mahindra Q1FY15 profits better than estimates - Hold - SPA Securities
Mahindra &Mahindra Q1FY15 profits better than estimates - Hold - SPA Securities
 
Godrej Consumer's Q4 results were slightly below expectations; Neutral
Godrej Consumer's Q4 results were slightly below expectations; NeutralGodrej Consumer's Q4 results were slightly below expectations; Neutral
Godrej Consumer's Q4 results were slightly below expectations; Neutral
 
Dabur ru2 qfy2011-271010
Dabur ru2 qfy2011-271010Dabur ru2 qfy2011-271010
Dabur ru2 qfy2011-271010
 
Daily equity report
Daily equity reportDaily equity report
Daily equity report
 
Procter & Gamble Analysis
Procter & Gamble AnalysisProcter & Gamble Analysis
Procter & Gamble Analysis
 
Sanofi India: Q2CY14 net rises 12.30%, maintain buy
 Sanofi India: Q2CY14 net rises 12.30%, maintain buy Sanofi India: Q2CY14 net rises 12.30%, maintain buy
Sanofi India: Q2CY14 net rises 12.30%, maintain buy
 
Pachin
PachinPachin
Pachin
 
Finacial comparison Godrej & Dabur
Finacial comparison Godrej & DaburFinacial comparison Godrej & Dabur
Finacial comparison Godrej & Dabur
 
Aviva plc Third Quarter 2014 Interim Management Statement
Aviva plc Third Quarter 2014 Interim Management StatementAviva plc Third Quarter 2014 Interim Management Statement
Aviva plc Third Quarter 2014 Interim Management Statement
 
Arabian Food Industries - Domty - Initiation of Coverage - October 2016
Arabian Food Industries - Domty - Initiation of Coverage - October 2016Arabian Food Industries - Domty - Initiation of Coverage - October 2016
Arabian Food Industries - Domty - Initiation of Coverage - October 2016
 
Cost of Capital ITC
Cost of Capital ITCCost of Capital ITC
Cost of Capital ITC
 
Colgate Palmolive: Long-term outlook remains encouraging; Accumulate
Colgate Palmolive: Long-term outlook remains encouraging; AccumulateColgate Palmolive: Long-term outlook remains encouraging; Accumulate
Colgate Palmolive: Long-term outlook remains encouraging; Accumulate
 
Narayan hrudyalaya Q1FY19
Narayan hrudyalaya Q1FY19Narayan hrudyalaya Q1FY19
Narayan hrudyalaya Q1FY19
 
DB Corp Q4FY15: Buy for a medium to long term investment
DB Corp Q4FY15: Buy for a medium to long term investmentDB Corp Q4FY15: Buy for a medium to long term investment
DB Corp Q4FY15: Buy for a medium to long term investment
 
Sharda Cropchem IPO: Reasonably priced; Subscribe - SPA Securities
Sharda Cropchem IPO: Reasonably priced; Subscribe - SPA SecuritiesSharda Cropchem IPO: Reasonably priced; Subscribe - SPA Securities
Sharda Cropchem IPO: Reasonably priced; Subscribe - SPA Securities
 
Aviva HY 2014 analyst presentation
Aviva HY 2014 analyst presentationAviva HY 2014 analyst presentation
Aviva HY 2014 analyst presentation
 
Aviva 2017 Interim Results announcement
Aviva 2017 Interim Results announcementAviva 2017 Interim Results announcement
Aviva 2017 Interim Results announcement
 
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
 

Similar to HUL registers profit in-line with street expectations in Q4FY15

Vivimed labs ltd_3QFY15 Presentation
Vivimed labs ltd_3QFY15 PresentationVivimed labs ltd_3QFY15 Presentation
Vivimed labs ltd_3QFY15 PresentationJigar Savla
 
Hindustan Unilever Q2FY15 result in line with estimtaes; buy
Hindustan Unilever Q2FY15 result in line with estimtaes; buyHindustan Unilever Q2FY15 result in line with estimtaes; buy
Hindustan Unilever Q2FY15 result in line with estimtaes; buyIndiaNotes.com
 
IndusInd Bank delivers strong set of numbers in Q4; Accumulate
IndusInd Bank delivers strong set of numbers in Q4; AccumulateIndusInd Bank delivers strong set of numbers in Q4; Accumulate
IndusInd Bank delivers strong set of numbers in Q4; AccumulateIndiaNotes.com
 
Hindustan Unilever Q4FY15: Net sales up 9% y/y to Rs7,555cr; Hold
Hindustan Unilever Q4FY15: Net sales up 9% y/y to Rs7,555cr; HoldHindustan Unilever Q4FY15: Net sales up 9% y/y to Rs7,555cr; Hold
Hindustan Unilever Q4FY15: Net sales up 9% y/y to Rs7,555cr; HoldIndiaNotes.com
 
Petronet LNG: Reports decent set of numbers, hold - Sushil Finance
Petronet LNG: Reports decent set of numbers, hold - Sushil FinancePetronet LNG: Reports decent set of numbers, hold - Sushil Finance
Petronet LNG: Reports decent set of numbers, hold - Sushil FinanceIndiaNotes.com
 
Sushil finance indusind_28oct_2014
Sushil finance indusind_28oct_2014Sushil finance indusind_28oct_2014
Sushil finance indusind_28oct_2014IndiaNotes.com
 
Dabur India Q1FY15: Maintain neutral
 Dabur India Q1FY15: Maintain neutral Dabur India Q1FY15: Maintain neutral
Dabur India Q1FY15: Maintain neutralIndiaNotes.com
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndiaNotes.com
 
Q2FY15: Hold Federal Bank for a target of Rs156 - Sushil Finance
Q2FY15: Hold Federal Bank for a target of Rs156 - Sushil FinanceQ2FY15: Hold Federal Bank for a target of Rs156 - Sushil Finance
Q2FY15: Hold Federal Bank for a target of Rs156 - Sushil FinanceIndiaNotes.com
 
Dabur Q4FY14 results in line with expectations by Motilal Oswal
Dabur Q4FY14 results in line with expectations by Motilal OswalDabur Q4FY14 results in line with expectations by Motilal Oswal
Dabur Q4FY14 results in line with expectations by Motilal OswalIndiaNotes.com
 
Jyothy Laboratories Q1FY15: Buy at CMP - HDFC Sec
Jyothy Laboratories Q1FY15: Buy at CMP - HDFC SecJyothy Laboratories Q1FY15: Buy at CMP - HDFC Sec
Jyothy Laboratories Q1FY15: Buy at CMP - HDFC SecIndiaNotes.com
 
Sun pharmaceutical industries ltd.
Sun pharmaceutical industries ltd.Sun pharmaceutical industries ltd.
Sun pharmaceutical industries ltd.AbhishekSoni260
 
Q4FY15 result update: IDFC profits trail street expectations
Q4FY15 result update: IDFC profits trail street expectationsQ4FY15 result update: IDFC profits trail street expectations
Q4FY15 result update: IDFC profits trail street expectationsIndiaNotes.com
 
Dabur Q3FY15: Mixed quarter; maintain neutral
 Dabur Q3FY15: Mixed quarter; maintain neutral Dabur Q3FY15: Mixed quarter; maintain neutral
Dabur Q3FY15: Mixed quarter; maintain neutralIndiaNotes.com
 
Marico: Q1FY15 numbers above estimates, maintain buy - HDFC Sec
Marico: Q1FY15 numbers above estimates, maintain buy - HDFC SecMarico: Q1FY15 numbers above estimates, maintain buy - HDFC Sec
Marico: Q1FY15 numbers above estimates, maintain buy - HDFC SecIndiaNotes.com
 
TCS Q1FY15: Results in-line, buy on dips
TCS Q1FY15: Results in-line, buy on dipsTCS Q1FY15: Results in-line, buy on dips
TCS Q1FY15: Results in-line, buy on dipsIndiaNotes.com
 
Investment Funds Advisory Today- Buy Stock of Escorts Ltd and Neutral View on...
Investment Funds Advisory Today- Buy Stock of Escorts Ltd and Neutral View on...Investment Funds Advisory Today- Buy Stock of Escorts Ltd and Neutral View on...
Investment Funds Advisory Today- Buy Stock of Escorts Ltd and Neutral View on...NARNOLIA SECURITIES LIMITED
 
HUL Q1FY15: Decent numbers; PAT grows 21.2% - HDFC Sec
HUL Q1FY15: Decent numbers; PAT grows 21.2% - HDFC SecHUL Q1FY15: Decent numbers; PAT grows 21.2% - HDFC Sec
HUL Q1FY15: Decent numbers; PAT grows 21.2% - HDFC SecIndiaNotes.com
 
Prak avenue raymond porter's five model 4ps
Prak avenue raymond porter's five model 4psPrak avenue raymond porter's five model 4ps
Prak avenue raymond porter's five model 4psKshitijPathak15
 
Buy Britannia Industries for a target of Rs1110 - Prabhudas Lilladher
Buy Britannia Industries for a target of Rs1110 - Prabhudas LilladherBuy Britannia Industries for a target of Rs1110 - Prabhudas Lilladher
Buy Britannia Industries for a target of Rs1110 - Prabhudas LilladherIndiaNotes.com
 

Similar to HUL registers profit in-line with street expectations in Q4FY15 (20)

Vivimed labs ltd_3QFY15 Presentation
Vivimed labs ltd_3QFY15 PresentationVivimed labs ltd_3QFY15 Presentation
Vivimed labs ltd_3QFY15 Presentation
 
Hindustan Unilever Q2FY15 result in line with estimtaes; buy
Hindustan Unilever Q2FY15 result in line with estimtaes; buyHindustan Unilever Q2FY15 result in line with estimtaes; buy
Hindustan Unilever Q2FY15 result in line with estimtaes; buy
 
IndusInd Bank delivers strong set of numbers in Q4; Accumulate
IndusInd Bank delivers strong set of numbers in Q4; AccumulateIndusInd Bank delivers strong set of numbers in Q4; Accumulate
IndusInd Bank delivers strong set of numbers in Q4; Accumulate
 
Hindustan Unilever Q4FY15: Net sales up 9% y/y to Rs7,555cr; Hold
Hindustan Unilever Q4FY15: Net sales up 9% y/y to Rs7,555cr; HoldHindustan Unilever Q4FY15: Net sales up 9% y/y to Rs7,555cr; Hold
Hindustan Unilever Q4FY15: Net sales up 9% y/y to Rs7,555cr; Hold
 
Petronet LNG: Reports decent set of numbers, hold - Sushil Finance
Petronet LNG: Reports decent set of numbers, hold - Sushil FinancePetronet LNG: Reports decent set of numbers, hold - Sushil Finance
Petronet LNG: Reports decent set of numbers, hold - Sushil Finance
 
Sushil finance indusind_28oct_2014
Sushil finance indusind_28oct_2014Sushil finance indusind_28oct_2014
Sushil finance indusind_28oct_2014
 
Dabur India Q1FY15: Maintain neutral
 Dabur India Q1FY15: Maintain neutral Dabur India Q1FY15: Maintain neutral
Dabur India Q1FY15: Maintain neutral
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
 
Q2FY15: Hold Federal Bank for a target of Rs156 - Sushil Finance
Q2FY15: Hold Federal Bank for a target of Rs156 - Sushil FinanceQ2FY15: Hold Federal Bank for a target of Rs156 - Sushil Finance
Q2FY15: Hold Federal Bank for a target of Rs156 - Sushil Finance
 
Dabur Q4FY14 results in line with expectations by Motilal Oswal
Dabur Q4FY14 results in line with expectations by Motilal OswalDabur Q4FY14 results in line with expectations by Motilal Oswal
Dabur Q4FY14 results in line with expectations by Motilal Oswal
 
Jyothy Laboratories Q1FY15: Buy at CMP - HDFC Sec
Jyothy Laboratories Q1FY15: Buy at CMP - HDFC SecJyothy Laboratories Q1FY15: Buy at CMP - HDFC Sec
Jyothy Laboratories Q1FY15: Buy at CMP - HDFC Sec
 
Sun pharmaceutical industries ltd.
Sun pharmaceutical industries ltd.Sun pharmaceutical industries ltd.
Sun pharmaceutical industries ltd.
 
Q4FY15 result update: IDFC profits trail street expectations
Q4FY15 result update: IDFC profits trail street expectationsQ4FY15 result update: IDFC profits trail street expectations
Q4FY15 result update: IDFC profits trail street expectations
 
Dabur Q3FY15: Mixed quarter; maintain neutral
 Dabur Q3FY15: Mixed quarter; maintain neutral Dabur Q3FY15: Mixed quarter; maintain neutral
Dabur Q3FY15: Mixed quarter; maintain neutral
 
Marico: Q1FY15 numbers above estimates, maintain buy - HDFC Sec
Marico: Q1FY15 numbers above estimates, maintain buy - HDFC SecMarico: Q1FY15 numbers above estimates, maintain buy - HDFC Sec
Marico: Q1FY15 numbers above estimates, maintain buy - HDFC Sec
 
TCS Q1FY15: Results in-line, buy on dips
TCS Q1FY15: Results in-line, buy on dipsTCS Q1FY15: Results in-line, buy on dips
TCS Q1FY15: Results in-line, buy on dips
 
Investment Funds Advisory Today- Buy Stock of Escorts Ltd and Neutral View on...
Investment Funds Advisory Today- Buy Stock of Escorts Ltd and Neutral View on...Investment Funds Advisory Today- Buy Stock of Escorts Ltd and Neutral View on...
Investment Funds Advisory Today- Buy Stock of Escorts Ltd and Neutral View on...
 
HUL Q1FY15: Decent numbers; PAT grows 21.2% - HDFC Sec
HUL Q1FY15: Decent numbers; PAT grows 21.2% - HDFC SecHUL Q1FY15: Decent numbers; PAT grows 21.2% - HDFC Sec
HUL Q1FY15: Decent numbers; PAT grows 21.2% - HDFC Sec
 
Prak avenue raymond porter's five model 4ps
Prak avenue raymond porter's five model 4psPrak avenue raymond porter's five model 4ps
Prak avenue raymond porter's five model 4ps
 
Buy Britannia Industries for a target of Rs1110 - Prabhudas Lilladher
Buy Britannia Industries for a target of Rs1110 - Prabhudas LilladherBuy Britannia Industries for a target of Rs1110 - Prabhudas Lilladher
Buy Britannia Industries for a target of Rs1110 - Prabhudas Lilladher
 

More from IndiaNotes.com

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15IndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesIndiaNotes.com
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoIndiaNotes.com
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityIndiaNotes.com
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16IndiaNotes.com
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtIndiaNotes.com
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...IndiaNotes.com
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...IndiaNotes.com
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CAREIndiaNotes.com
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...IndiaNotes.com
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16EIndiaNotes.com
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...IndiaNotes.com
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyIndiaNotes.com
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15IndiaNotes.com
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyIndiaNotes.com
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetIndiaNotes.com
 

More from IndiaNotes.com (20)

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debt
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARE
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16E
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, Buy
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
 

Recently uploaded

Instant Issue Debit Cards - High School Spirit
Instant Issue Debit Cards - High School SpiritInstant Issue Debit Cards - High School Spirit
Instant Issue Debit Cards - High School Spiritegoetzinger
 
Dividend Policy and Dividend Decision Theories.pptx
Dividend Policy and Dividend Decision Theories.pptxDividend Policy and Dividend Decision Theories.pptx
Dividend Policy and Dividend Decision Theories.pptxanshikagoel52
 
20240429 Calibre April 2024 Investor Presentation.pdf
20240429 Calibre April 2024 Investor Presentation.pdf20240429 Calibre April 2024 Investor Presentation.pdf
20240429 Calibre April 2024 Investor Presentation.pdfAdnet Communications
 
Lundin Gold April 2024 Corporate Presentation v4.pdf
Lundin Gold April 2024 Corporate Presentation v4.pdfLundin Gold April 2024 Corporate Presentation v4.pdf
Lundin Gold April 2024 Corporate Presentation v4.pdfAdnet Communications
 
VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130
VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130
VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130Suhani Kapoor
 
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...Henry Tapper
 
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...shivangimorya083
 
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...Suhani Kapoor
 
VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...
VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...
VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...Suhani Kapoor
 
VIP Kolkata Call Girl Serampore 👉 8250192130 Available With Room
VIP Kolkata Call Girl Serampore 👉 8250192130  Available With RoomVIP Kolkata Call Girl Serampore 👉 8250192130  Available With Room
VIP Kolkata Call Girl Serampore 👉 8250192130 Available With Roomdivyansh0kumar0
 
VIP Call Girls in Saharanpur Aarohi 8250192130 Independent Escort Service Sah...
VIP Call Girls in Saharanpur Aarohi 8250192130 Independent Escort Service Sah...VIP Call Girls in Saharanpur Aarohi 8250192130 Independent Escort Service Sah...
VIP Call Girls in Saharanpur Aarohi 8250192130 Independent Escort Service Sah...Suhani Kapoor
 
VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...
VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...
VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...Call Girls in Nagpur High Profile
 
Best VIP Call Girls Noida Sector 18 Call Me: 8448380779
Best VIP Call Girls Noida Sector 18 Call Me: 8448380779Best VIP Call Girls Noida Sector 18 Call Me: 8448380779
Best VIP Call Girls Noida Sector 18 Call Me: 8448380779Delhi Call girls
 
Q3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast SlidesQ3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast SlidesMarketing847413
 
Call US 📞 9892124323 ✅ Kurla Call Girls In Kurla ( Mumbai ) secure service
Call US 📞 9892124323 ✅ Kurla Call Girls In Kurla ( Mumbai ) secure serviceCall US 📞 9892124323 ✅ Kurla Call Girls In Kurla ( Mumbai ) secure service
Call US 📞 9892124323 ✅ Kurla Call Girls In Kurla ( Mumbai ) secure servicePooja Nehwal
 
Instant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School DesignsInstant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School Designsegoetzinger
 
Call Girls In Yusuf Sarai Women Seeking Men 9654467111
Call Girls In Yusuf Sarai Women Seeking Men 9654467111Call Girls In Yusuf Sarai Women Seeking Men 9654467111
Call Girls In Yusuf Sarai Women Seeking Men 9654467111Sapana Sha
 

Recently uploaded (20)

Instant Issue Debit Cards - High School Spirit
Instant Issue Debit Cards - High School SpiritInstant Issue Debit Cards - High School Spirit
Instant Issue Debit Cards - High School Spirit
 
Dividend Policy and Dividend Decision Theories.pptx
Dividend Policy and Dividend Decision Theories.pptxDividend Policy and Dividend Decision Theories.pptx
Dividend Policy and Dividend Decision Theories.pptx
 
20240429 Calibre April 2024 Investor Presentation.pdf
20240429 Calibre April 2024 Investor Presentation.pdf20240429 Calibre April 2024 Investor Presentation.pdf
20240429 Calibre April 2024 Investor Presentation.pdf
 
Lundin Gold April 2024 Corporate Presentation v4.pdf
Lundin Gold April 2024 Corporate Presentation v4.pdfLundin Gold April 2024 Corporate Presentation v4.pdf
Lundin Gold April 2024 Corporate Presentation v4.pdf
 
🔝+919953056974 🔝young Delhi Escort service Pusa Road
🔝+919953056974 🔝young Delhi Escort service Pusa Road🔝+919953056974 🔝young Delhi Escort service Pusa Road
🔝+919953056974 🔝young Delhi Escort service Pusa Road
 
VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130
VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130
VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130
 
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
 
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
 
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
 
Veritas Interim Report 1 January–31 March 2024
Veritas Interim Report 1 January–31 March 2024Veritas Interim Report 1 January–31 March 2024
Veritas Interim Report 1 January–31 March 2024
 
VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...
VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...
VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...
 
VIP Kolkata Call Girl Serampore 👉 8250192130 Available With Room
VIP Kolkata Call Girl Serampore 👉 8250192130  Available With RoomVIP Kolkata Call Girl Serampore 👉 8250192130  Available With Room
VIP Kolkata Call Girl Serampore 👉 8250192130 Available With Room
 
VIP Call Girls in Saharanpur Aarohi 8250192130 Independent Escort Service Sah...
VIP Call Girls in Saharanpur Aarohi 8250192130 Independent Escort Service Sah...VIP Call Girls in Saharanpur Aarohi 8250192130 Independent Escort Service Sah...
VIP Call Girls in Saharanpur Aarohi 8250192130 Independent Escort Service Sah...
 
VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...
VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...
VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...
 
Monthly Economic Monitoring of Ukraine No 231, April 2024
Monthly Economic Monitoring of Ukraine No 231, April 2024Monthly Economic Monitoring of Ukraine No 231, April 2024
Monthly Economic Monitoring of Ukraine No 231, April 2024
 
Best VIP Call Girls Noida Sector 18 Call Me: 8448380779
Best VIP Call Girls Noida Sector 18 Call Me: 8448380779Best VIP Call Girls Noida Sector 18 Call Me: 8448380779
Best VIP Call Girls Noida Sector 18 Call Me: 8448380779
 
Q3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast SlidesQ3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast Slides
 
Call US 📞 9892124323 ✅ Kurla Call Girls In Kurla ( Mumbai ) secure service
Call US 📞 9892124323 ✅ Kurla Call Girls In Kurla ( Mumbai ) secure serviceCall US 📞 9892124323 ✅ Kurla Call Girls In Kurla ( Mumbai ) secure service
Call US 📞 9892124323 ✅ Kurla Call Girls In Kurla ( Mumbai ) secure service
 
Instant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School DesignsInstant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School Designs
 
Call Girls In Yusuf Sarai Women Seeking Men 9654467111
Call Girls In Yusuf Sarai Women Seeking Men 9654467111Call Girls In Yusuf Sarai Women Seeking Men 9654467111
Call Girls In Yusuf Sarai Women Seeking Men 9654467111
 

HUL registers profit in-line with street expectations in Q4FY15

  • 1. Standalone Results In Cr. Particulars Qtr Ending Qtr Ending Mar 15 Mar 14 Var. (%) Sales 7675.63 7094.10 8 OPM (%) 17.20 15.20 OP 1318.18 1077.55 22 Other Income 98.41 150.63 -35 PBIDT 1416.59 1228.18 15 Interest (Income)/expenses 0.00 5.33 -100 PBDT 1416.59 1222.85 16 Depreciation 70.52 65.77 7 PBT before EO 1346.07 1157.08 16 Exceptional Items 179.40 66.03 172 PBT after EO 1525.47 1223.11 25 Total Tax 507.39 350.98 45 Net profit 1018.08 872.13 17 EPS 4.71 4.03 May 14, 2015Hindustan Unilever Limited Current Price: Price (`) 843.05 52 W H/L(`) 979.00/554.55 Mkt. Cap.(` Cr) 182390.91 Latest Equity(Subscribed) 216.35 Latest Reserve 3507.76 Latest EPS-Unit Curr. 17.80 Latest P/E Ratio 47.36 Latest Bookvalue -Unit Curr. 17.21 Latest P/BV 48.99 Dividend Yield -% 1.54 Face Value 1.00 VALUE PARAMETERS `843.05 STOCK DATA BSE Code 500696 NSE Symbol HINDUNILVR Reuters HLL.BO Bloomberg HUVR IN Hindustan Unilever (HUL) matched street estimates with the fourth quarter profit rising 16.7 percent year-on-year to `1,018 crore compared to `872 crore in the year-ago period. The net sales have increased by 8% to `7675.63 crore. The Domestic Consumer business grew at 9%, with 6% underlying volume growth, both ahead of market. In Soaps and Detergents, growth sustained. Skin Cleansing delivered volume-led growth driven by Lifebuoy, Liril and Pears. The liquids portfolio registered another strong quarter led by Lifebuoy Handwash. In Laundry, growth was led by the premium segment with Surf maintaining its volume led double digit growth momentum and Rin delivering good growth on the bars portfolio. Comfort Fabric Conditioners continued to do well. Vim led the performance in Household Care. The quarter witnessed price deflation across these categories, as the benefit of lower commodity costs was passed on to consumers. Personal Products growth steps up across all categories. Skin Care delivered double digit growth driven by Fair and Lovely and Pond's. Fair and Lovely continued to perform well while Pond's growth was led by premium skin lightening and talc. Hair Care sustained its strong volume led growth momentum with broad based double digit growth. Dove led the category performance while Clinic Plus, Sunsilk and TRESemmé continued to make very good progress. In Oral Care, Close Up registered double digit growth on the back of impactful activation. Pepsodent growth was driven by Gum Care and Clove & Salt variants. Colour Cosmetics delivered innovation led double digit growth with Lakme continuing to strengthen its position in premium make up, driven by a range of exciting and contemporary offerings from Absolute and 9 to 5. Beverages had strong growth in Tea and Coffee. Tea delivered double digit growth led by Taj Mahal, Red Label and 3 Roses. Lipton Green Tea registered another quarter of high growth on sustained market development. In Coffee, the performance was driven by Bru Gold, which continued to lead category premiumization. 1 SHARE HOLDING PATTERN (%) Description as on % of Holding 31/03/2015 Foreign 15.37 Institutions 3.82 Non Promoter Corp. Hold. 1.13 Promoters 67.23 Public & Others 12.45 ®
  • 2. 2 Standalone Segmented Results In Cr. Particulars Qtr Ending Qtr Ending Var % Mar 15 Mar 14 (%) of total Soaps & Detergents 3673.71 3497.12 5 48 Personal Products 2249.68 1983.29 13 29 Beverages 976.15 869.04 12 13 Packaged Foods 476.83 419.68 14 6 Others 294.70 295.79 0 4 Total 7671.07 7064.92 9 100 Segment Results (PBIT) Soaps & Detergents 488.25 421.71 16 37 Personal Products 624.52 495.81 26 48 Beverages 181.61 163.04 11 14 Packaged Foods 25.40 22.96 11 2 Others -7.83 -25.05 -69 -1 TOTAL 1311.95 1078.47 22 100 Packaged Foods had sixth successive quarter of double digit growth. Market development continues to be the focus, resulting in double digit growth across all key brands. Kissan sustained its strong activation-led growth momentum while Knorr registered volume led growth as Instant Soups more than doubled sales and new Chinese flavours were added to the Noodles portfolio. Ice Creams delivered another strong quarter, led by Magnum and sharper in- market execution on Kwality Walls. A new variant, Magnum Choco Cappuccino was introduced during the season. Pureit growth was led by the premium segment with Ultima (RO+UV) continuing to deliver strongly. The quarter saw the launch of a new Marvella (RO+UV) device. Input costs were benign and this is reflected in the reduction in cost of goods sold. Investment behind brands was sustained at competitive levels. The margin for the quarter includes a one- time credit of Rs 71.5 crore towards a favourable outcome for a contested matter on Excise Duty. As a result, OPM inclined by 198 bps to 17.2%. There was fall in raw material cost by 220 bps to 38.08%, purchase of traded goods by 128 bps to 11.88%, employee cost by 20 bps to 5.05% and other cost by 30 bps to 14.49% of adjusted net sales. However, there was rise advertisement & promotion (ASP) cost by 170 bps to 13.36% of adjusted net sales. The operating profit inclined by 22% to `1318.18 crore. Other income has decreased by 35% to `98.41 crore, which includes interest income, dividend income and net gain on sale of other non-trade current investments. Depreciation inclined by 7% to `70.52 crore. Profit before tax and exceptional item inclined by 16% to Rs 1346.07 crore. There was an exceptional income of `179.40 crore, growth of 172%. Exceptional items includes profit on sale of surplus properties `70.7 crore, profit on sale of wholly owned subsidiary Brooke Bond Real Estate Pvt Ltd `168.97 crore, reduction in provision for retirement benefit arising out of change in actuarial assumption of `5.37 crore and restructuring cost of `2.02 crore. The profit before tax and after exceptional items has inclined by 25% to `1525.47 crore. Tax outgo has increased by 45% to `507.39 crore. The effective tax rate was increased from 28.69% to 33.26%. The net profit has increased by 17% to Rs 1018.08 crore due to increase in OPM and EO income. ®
  • 3. 3 ® Segmented results Soaps & detergents: At standalone level, the revenue has increased by 5% to `3673.71 crore for Q4 FY15. PBIT margins had inclined by 120 bps to 13.3%. As a result, PBIT had increased by 16% to `488.25 crore. The category contributed around 48% to the revenues while the contribution to PBIT stood at 37%. Personal care: At standalone level, the revenues grew 13% to `2249.68 crore for Q4 FY15. PBIT margin have increased by 280 bps to 27.8%. As a result, the PBIT has increased by 26% to `624.52 crore. The category contributed around 29% to the revenues while the contribution to PBIT stood 48%. Beverages: At standalone level, the sales grew by 12% to `976.15 crore for Q4 FY15. The segment contributed 13% to the total revenues. PBIT margin has declined by 20 bps to 18.6%. As a result, PBIT has inclined by 11% to `181.61 crore. It contributes 14% to the total PBIT. Packaged Foods: At standalone level, the sales have increased by 14% to `476.83 crore for Q4 FY15. The segment contributed 6% to the total revenues. PBIT margin declined by 14 bps to 5.3%.The PBIT has increased by11% to Rs 25.40 crore. Other Business At standalone level, the sales stood at `294.70 crore for Q4 FY15. The segment contributed 4% to the total revenues. The loss at PBIT level decreased by 69% to `7.83 crore. Other Developments The Board of Directors has proposed a final dividend of `9 per share, subject to the approval of the shareholders at the AGM. Together with the interim dividend of `6 per share, the total dividend for the financial year ending 31st March, 2015 amounts to `15 per share. Management Comments Harish Manwani, Chairman commented: We have delivered another year of strong performance with broad based growth ahead of the market and sustained margin improvement. Our strategy remains focused on strengthening the core of our business through innovation, leading market development and continuous improvement of our executional capabilities. Despite market challenges, our strategic agenda remains unchanged as we continue to manage our business even more dynamically for growth that is consistent, competitive, profitable and responsible.
  • 4. 4 ® SMC Global Securities Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, a further public offering of its equity shares and has filed the Draft Red Herring Prospectus with the Securities and Exchange Board of India (“SEBI”) and the Stock Exchanges. The Draft Red Herring Prospectus is available on the website of SEBI at www.sebi.gov.in and on the websites of the Book Running Lead Manager i.e., ICICI Securities Limited at www.icicisecurities.com and the Co- Book Running Lead Manager i.e., Elara Capital (India) Private Limited at www.elaracapital.com . Investors should note that investment in equity shares involves a high degree of risk and for details relating to the same, please see the section titled “Risk Factors” of the aforementioned offer document. Disclaimer: This report is for the personal information of the authorized recipient and doesn't construe to be any investment, legal or taxation advice to you. It is only for private circulation and use .The report is based upon information that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied upon as such. No action is solicited on the basis of the contents of the report. The report should not be reproduced or redistributed to any other person(s)in any form without prior written permission of the SMC. The contents of this material are general and are neither comprehensive nor inclusive. Neither SMC nor any of its affiliates, associates, representatives, directors or employees shall be responsible for any loss or damage that may arise to any person due to any action taken on the basis of this report. It does not constitute personal recommendations or take into account the particular investment objectives, financial situations or needs of an individual client or a corporate/s or any entity/s.All investments involve risk and past performance doesn't guarantee future results. The value of, and income from investments may vary because of the changes in the macro and micro factors given at a certain period of time. The person should use his/her own judgment while taking investment decisions. Please note that we and our affiliates, officers, directors, and employees, including persons involved in the preparation or issuance if this material;(a) from time to time, may have long or short positions in, and buy or sell the securities thereof, of company (ies) mentioned here in or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company (ies) discussed herein or may perform or seek to perform investment banking services for such company(ies) or act as advisor or lender/borrower to such company(ies) or (c) may have any other potential conflict of interest with respect to any recommendation and related information and opinions.All disputes shall be subject to the exclusive jurisdiction of Delhi High court. Corporate Office: 11/6B, Shanti Chamber, Pusa Road, New Delhi - 110005 Tel: +91-11-30111000 www.smcindiaonline.com Mumbai Office: Dheeraj Sagar, 1st Floor, Opp. Goregaon sports club, link road Malad (West), Mumbai - 400064 Tel: 91-22-67341600, Fax: 91-22-28805606 Kolkata Office: 18, Rabindra Sarani, "Poddar Court", Gate No. 4, 4th Floor, Kolkata - 700001 Tel: 91-33-39847000, Fax: 91-33-39847004 E-mail: researchfeedback@smcindiaonline.com ® SMC Research also available on Reuters SMC Global Securities Ltd. (hereinafter referred to as “SMC”) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited and its associate is member of MCX stock Exchange Limited. It is also registered as a Depository Participant with CDSL and NSDL. Its associates merchant banker and Portfolio Manager are registered with SEBI and NBFC registered with RBI. It also has registration withAMFI as a Mutual Fund Distributor. SMC is in the process of making an application with SEBI for registering as a Research Entity in terms of SEBI (Research Analyst) Regulations, 2014. SMC or its associates has not been debarred/ suspended by SEBI or any other regulatory authority for accessing /dealing in securities Market. SMC or its associates including its relatives/analyst do not hold any financial interest/beneficial ownership of more than 1% in the company covered byAnalyst. SMC or its associates and relatives does not have any material conflict of interest. SMC or its associates/analyst has not received any compensation from the company covered byAnalyst during the past twelve months. The subject company has not been a client of SMC during the past twelve months. SMC or its associates has not received any compensation or other benefits from the company covered by analyst or third party in connection with the research report. TheAnalyst has not served as an officer, director or employee of company covered byAnalyst and SMC has not been engaged in market making activity of the company covered byAnalyst. The views expressed are based solely on information available publicly available/internal data/ other reliable sources believed to be true. SMC does not represent/ provide any warranty express or implied to the accuracy, contents or views expressed herein and investors are advised to independently evaluate the market conditions/risks involved before making any investment decision. SMC Research Desk